Sort
326,823 grants matching “clinical trial”
COSTIMULATION BLOCKADE FOR PRIMATE RENAL TRANSPLANTATION
$1,653,009Henry M. Jackson Fdn For The Adv Mil/Med · U19 · FY2000 · AI
Hyperandrogenemia, Diet and Female Reproductive Health
$1,652,887Jon D Hennebold · Oregon Health & Science University · P50 · FY2021 · HD
Discovering existing medicines that abrogate cellular responses to SARS CoV-2 infection
$1,652,790Todd R. Golub · Broad Institute, Inc. · U54 · FY2020 · HL
EINSTEIN AGING STUDY
$1,652,762Yeshiva University · P01 · FY2001 · AG
NIAMS: CORT
$1,652,583Robert A Lafyatis · Boston University Medical Campus · P50 · FY2011 · AR
The MW Cancer Prevention Clinical Trials Network
$1,652,564Howard H Bailey · University Of Wisconsin-Madison · UG1 · FY2022 · CA
Hormonal, Metabolic and Signaling Interactions in PAH
$1,652,537Anna R Hemnes · Vanderbilt University Medical Center · P01 · FY2020 · HL
Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patents initiating medication-assisted treatment
$1,652,477Luis J. Montaner · Wistar Institute · R01 · FY2022 · DA
Centers for AIDS Research (CFAR)
$1,652,403Kent J. Weinhold · Duke University · P30 · FY2015 · AI
A Humanized Monoclonal FSH Blocking Antibody for Alzheimer's Disease
$1,652,369Mone Zaidi · Icahn School Of Medicine At Mount Sinai · U01 · FY2024 · AG
Waisman Intellectual and Developmental Disabilities Research Center
$1,652,183Albee Messing · University Of Wisconsin-Madison · P30 · FY2015 · HD
Development/production of universal influenza vaccines
$1,652,145Jason Gall · National Institute Of Allergy And Infectious Diseases · ZIB · FY2021 · AI
REGIONAL ALLOGENEIC MESOTHELIN-TARGETED CAR (RAMCAR) T-CELL THERAPY FOR ESOPHAGEAL CANCER: CLINICAL TRIAL PREPARATION AND PHASE 1 CLINICAL TRIAL
$1,651,948Sloan-Kettering Institute For Cancer Research · · FY2021 · Defense Health Agency
Directing Tumor-specific T cells to Tumors
$1,651,765Pawel Kalinski · University Of Pittsburgh At Pittsburgh · P01 · FY2012 · CA
PHASE II/III trial for Slowing Progression in Mild Cognitive Impairment
$1,651,734Michela Gallagher · Johns Hopkins University · R01 · FY2015 · AG
NCI Community Oncology Research Program (NCORP) Minority/Underserved Community Sites
$1,651,700Carolyn Y Muller · University Of New Mexico Health Scis Ctr · UG1 · FY2021 · CA
Partnership for Prevention of HPV-Associated Cancers in People Living with HIV: Brazil, Mexico, and Puerto Rico
$1,651,550Timothy J Wilkin · Weill Medical Coll Of Cornell Univ · U54 · FY2021 · CA
Vaccine Immunotoxin and Radioimmunotherapy of Primary and Metastatic CNS Tumors
$1,651,535Darell D Bigner · Duke University · P01 · FY2012 · CA
IL-2IL-15 cytokine receptor: implications for cancer therapy and vaccine
$1,651,519Thomas Waldmann · Division Of Clinical Sciences - Nci · ZIA · FY2014 · CA
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy
$1,651,519Thomas Waldmann · Division Of Basic Sciences - Nci · ZIB · FY2014 · CA
Efficacy of kTMP, a novel non-invasive brain stimulation method, for the treatment of anhedonia patients.
$1,651,499Ludovica Labruna · Magnetic Tides, Inc. · R44 · FY2025 · MH
Southern Consortium Node of the Clinical Trials Network
$1,651,467Kathleen Theresa Brady · Medical University Of South Carolina · UG1 · FY2021 · DA
Cellular and Molecular Studies of Bone Marrow Transplant
$1,651,429James L M Ferrara · Icahn School Of Medicine At Mount Sinai · P01 · FY2014 · CA
Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
$1,651,264Timothy Church · University Of Minnesota · N01 · FY2010 · CA
NIH Health Care Systems Research Collaboratory - Coordinating Center
$1,651,262Adrian Hernandez · Duke University · U24 · FY2017 · AT